National Institutes of Health

Description

Purpose. The National Institute on Drug Abuse (NIDA), through the issuance of this program announcement, with set aside funds (PAS), invites Phased Innovation (R21/R33) grant applications from new-to-NIH investigators into basic chemistry research applied to drug abuse and addiction. NIDA invites newly independent investigators and investigators who have not had previous NIH funding to submit applications for research projects related to NIDAs mission. Mechanism of Support. This FOA will utilize the Exploratory/Developmental Phased Innovation (R21/R33) grant mechanism. Applicants will submit a single application organized into two phases, beginning with discussion of the R21 phase followed by discussion of the R33 phase. Applicants using only the R21 mechanism or only the R33 mechanism will not be considered. Funds Available and Anticipated Number of Awards. NIDA intends to commit approximately $1,500,000 in FY 2011 to fund 6 to 8 grants. Funding will be based on scientific and technical merit, program priorities, and availability of funds. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award also will vary.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV